Craneware plc
("Craneware" or the "Company")
Exercise of Share Options
18 September 2024 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 16 September 2024, the three Executive Directors of the Company exercised share options over ordinary shares of 1p each in the Company ("Ordinary Shares") in accordance with the terms of the Company's relevant employee share option plans. The net amount of Ordinary Shares received by these three Directors, as shown in the table below, from the exercise of these share options was after settlement of the exercise cost and applicable income tax and national insurance contributions:
Director |
Share Option Exercise price per share |
Number of Ordinary Shares subject to the share option
|
Number of Ordinary Shares withheld to satisfy exercise cost and tax liabilities on exercise of share option |
Net number of Ordinary Shares received from exercise of share option
|
Percentage of issued share capital* of the Company |
|
|
|
|
|
|
Keith Neilson (CEO) |
|
39,090 |
(24,125) |
14,965 |
0.042% |
|
|
|
|
|
|
Craig Preston (CFO) |
|
26,925 |
(17,991) |
8,934
|
0.025% |
|
8,586 |
(6,334) |
2,252 |
0.006% |
|
|
|
|
|
|
|
Isabel Urquhart (CPO) |
|
3,660 |
(2,347) |
1,313 |
0.004% |
|
|
|
|
|
|
*excluding 199,892 Ordinary Shares held in treasury (refer to Total Voting Rights section below).
Following these transactions, Keith Neilson holds 3,058,922 Ordinary Shares, representing 8.66% of the total voting rights of the Company, Craig Preston holds 87,603 Ordinary Shares, representing 0.25% of the total voting rights of the Company and Isabel Urquhart holds 10,558 Ordinary Shares, representing 0.03% of the total voting rights of the Company. The total voting rights of the Company are described below.
Total Voting Rights
Following the share option exercise transactions and also the exercise of share options by certain other employees on 16 September 2024, the Company is transferring a total of 23,372 Ordinary Shares previously held in treasury to satisfy share option exercise transactions.
As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 199,892 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,342,277. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:
PDMR notification: Keith Neilson
1. Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
2. Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary Shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Exercise of options over Ordinary Shares
2) Surrender of Ordinary Shares to satisfy exercise cost and tax liabilities on share option exercise
d) Price(s) and volume(s) 1) Volume(s) 39,090, Price(s)
2) Volumes(s) 24,125, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 39,090
2) 24,125
ii. Price 1)
2)
f) Date of the transaction 2024-09-16
g) Place of the transaction Outside a trading venue
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
2. Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Exercise of options over Ordinary Shares
2) Surrender of Ordinary Shares to satisfy exercise cost and tax liabilities on share option
d) Price(s) and volume(s) 1) Volume(s) 26,925, Price(s)
2) Volumes(s) 17,991, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 26,925
2) 17,991
ii. Price 1)
2)
f) Date of the transaction 2024-09-16
g) Place of the transaction Outside a trading venue
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
2. Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Exercise of options over Ordinary Shares
2) Surrender of Ordinary Shares to satisfy exercise cost and tax liabilities on share option
d) Price(s) and volume(s) 1) Volume(s) 8,586, Price(s)
2) Volumes(s) 6,334, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 8,586
2) 6,334
ii. Price 1)
2)
f) Date of the transaction 2024-09-16
g) Place of the transaction Outside a trading venue
PDMR notification: Isabel Urquhart
1. Details of the Restricted Person / person closely associated with him or her
a) Name Isabel Urquhart
2. Reason for the notification
a) Position / status Chief People Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Exercise of options over Ordinary Shares
2) Surrender of Ordinary Shares to satisfy exercise cost and tax liabilities on share option exercise
d) Price(s) and volume(s) 1) Volume(s) 3,660, Price(s)
2) Volumes(s) 2,347, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 3,660
2) 2,347
ii. Price 1)
2)
f) Date of the transaction 2024-09-16
g) Place of the transaction Outside a trading venue
For further information, please contact:
Craneware plc |
+44 (0)131 550 3100 |
Keith Neilson, CEO |
|
Craig Preston, CFO |
|
|
|
Alma Strategic Communications (Financial PR) |
+44 (0)20 3405 0205 |
Caroline Forde, Kinvara Verdon |
craneware@almastrategic.com |
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
|
|
Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
Patrick Robb, Henry Reast, Shalin Bhamra |
|
|
|
Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
Mark Whitmore, Richard Andrews, Dan Gee-Summons |
|
About Craneware
The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management.
Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.